Concepedia

Author

M. Wenczl

Markusovszky Egyetemi Oktatókórház

Also Known As

M. Wenczl, M.W. Wenczl, Miklos Wenczl, Miklós Wenczl

18

Publications

2K

Citations

7

H-Index

16

Concepts

All Affiliations

Markusovszky Egyetemi OktatókórházEge UniversityInstitut Claudius RegaudGreater Poland Cancer CenterUniversità Cattolica del Sacro Cuore
MW

About

M. Wenczl is an author at Markusovszky Egyetemi Oktatókórház specializing in cancer therapeutics, radiation oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

1.8K

2

Pharmacology

3

3

1.5K

3

Health Sciences

1

1

87

4

Gastroenterology

1

1

87

5

Pathology

1

1

1.1K

M. Wenczl

×

7

Publications

2K

Citations

7

H-Index

YearCitations

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran,

The Lancet Oncology

2017

1.1K

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

Magdolna Dank, J. Załuski, Carlo Barone,

Annals of Oncology

2008

342

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

Thomas Brodowicz, Maciej Krzakowski, Matjaž Zwitter,

Lung Cancer

2006

322

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial

Rosalind A. Eeles, James P. Morden, Martin Gore,

Journal of Clinical Oncology

2015

128

Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1<sup>st</sup>-line advanced gastric cancer patients

Magdolna Dank, J. Załuski, C. Barone,

Journal of Clinical Oncology

2005

87

Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

Desmond Curran, Carmelo Pozzo, Carlo Barone,

Quality of Life Research

2009

38

O-88 Gemcitabine and cisplatin (GC) +/-subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)

Maciel Krzakowski, M. Wenczl, Thomas Brodowicz,

Lung Cancer

2003

11

Page 1